chevron-orange.svg
Scientific References

DecisionDx® DiffDx-Melanoma is Clinically Validated to Aid Dermatopathologists in Difficult-to-Diagnose Melanocytic Lesions

Winter Clinical 2021

Performance of a 35-Gene Expression Profile Test in Suspicious Pigmented Lesions of the Head and Neck

Cockerell, C, Goldberg, MS, Estrada, SI, et al. Poster #007

winter

35-GEP Test Utilization in Lesions of the Head and Neck,
(#WC21 Poster #007)
Presented at the American Society of Dermatopathology
57th Annual Meeting

~51%
Increase in
diagnostic
confidence

42.2%
Decrease in
diagnostic
work-up
requests

Clinical Utility Study

A 35-Gene Expression Profile Test for Use in Suspicious Pigmented Lesions Impacts Clinical Management Decisions of Dermatopathologists and Dermatologists

Farberg AS, Ahmed KL, Bailey CN, et al. SKIN: J Cutan Med 2020 4(6), 523-533.

Clinical Validation Study

35 GEP Graphic_medium width

Clinical Validation Poster, (#ASDP20 Poster #296) Presented at the American Society of Dermatopathology 57th Annual Meeting

ASDP 2020

Development and validation of a diagnostic gene expression profile test for ambiguous or difficult-to-diagnose pigmented skin lesions

Estrada, SI, Shackelton, JB, Cleaver, NJ, et al. ASDP20 Poster #296

Publications

DiffDx-Melanoma Clinical Utility Studies

Scroll to Top